238 related articles for article (PubMed ID: 24161012)
1. Comprehensive profiling of Epstein-Barr virus-encoded miRNA species associated with specific latency types in tumor cells.
Yang HJ; Huang TJ; Yang CF; Peng LX; Liu RY; Yang GD; Chu QQ; Huang JL; Liu N; Huang HB; Zhu ZY; Qian CN; Huang BJ
Virol J; 2013 Oct; 10():314. PubMed ID: 24161012
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive profiling of functional Epstein-Barr virus miRNA expression in human cell lines.
Hooykaas MJ; Kruse E; Wiertz EJ; Lebbink RJ
BMC Genomics; 2016 Aug; 17():644. PubMed ID: 27531524
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma.
Cosmopoulos K; Pegtel M; Hawkins J; Moffett H; Novina C; Middeldorp J; Thorley-Lawson DA
J Virol; 2009 Mar; 83(5):2357-67. PubMed ID: 19091858
[TBL] [Abstract][Full Text] [Related]
4. Quantitative studies of Epstein-Barr virus-encoded microRNAs provide novel insights into their regulation.
Amoroso R; Fitzsimmons L; Thomas WA; Kelly GL; Rowe M; Bell AI
J Virol; 2011 Jan; 85(2):996-1010. PubMed ID: 21068248
[TBL] [Abstract][Full Text] [Related]
5. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
[TBL] [Abstract][Full Text] [Related]
6. A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia.
Qiu J; Cosmopoulos K; Pegtel M; Hopmans E; Murray P; Middeldorp J; Shapiro M; Thorley-Lawson DA
PLoS Pathog; 2011 Aug; 7(8):e1002193. PubMed ID: 21901094
[TBL] [Abstract][Full Text] [Related]
7. Clustered microRNAs of the Epstein-Barr virus cooperatively downregulate an epithelial cell-specific metastasis suppressor.
Kanda T; Miyata M; Kano M; Kondo S; Yoshizaki T; Iizasa H
J Virol; 2015 Mar; 89(5):2684-97. PubMed ID: 25520514
[TBL] [Abstract][Full Text] [Related]
8. Next-generation sequencing of miRNAs in clinical samples of Epstein-Barr virus-associated B-cell lymphomas.
Sakamoto K; Sekizuka T; Uehara T; Hishima T; Mine S; Fukumoto H; Sato Y; Hasegawa H; Kuroda M; Katano H
Cancer Med; 2017 Mar; 6(3):605-618. PubMed ID: 28181423
[TBL] [Abstract][Full Text] [Related]
9. Regulation network and expression profiles of Epstein-Barr virus-encoded microRNAs and their potential target host genes in nasopharyngeal carcinomas.
Zeng Z; Huang H; Huang L; Sun M; Yan Q; Song Y; Wei F; Bo H; Gong Z; Zeng Y; Li Q; Zhang W; Li X; Xiang B; Li X; Li Y; Xiong W; Li G
Sci China Life Sci; 2014 Mar; 57(3):315-326. PubMed ID: 24532457
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus BART9 miRNA modulates LMP1 levels and affects growth rate of nasal NK T cell lymphomas.
Ramakrishnan R; Donahue H; Garcia D; Tan J; Shimizu N; Rice AP; Ling PD
PLoS One; 2011; 6(11):e27271. PubMed ID: 22102884
[TBL] [Abstract][Full Text] [Related]
11. Integrated analysis of the differential cellular and EBV miRNA expression profiles in microdissected nasopharyngeal carcinoma and non-cancerous nasopharyngeal tissues.
Wan XX; Yi H; Qu JQ; He QY; Xiao ZQ
Oncol Rep; 2015 Nov; 34(5):2585-601. PubMed ID: 26330189
[TBL] [Abstract][Full Text] [Related]
12. EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency.
Riley KJ; Rabinowitz GS; Yario TA; Luna JM; Darnell RB; Steitz JA
EMBO J; 2012 May; 31(9):2207-21. PubMed ID: 22473208
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr Virus MicroRNA miR-BART5-3p Inhibits p53 Expression.
Zheng X; Wang J; Wei L; Peng Q; Gao Y; Fu Y; Lu Y; Qin Z; Zhang X; Lu J; Ou C; Li Z; Zhang X; Liu P; Xiong W; Li G; Yan Q; Ma J
J Virol; 2018 Dec; 92(23):. PubMed ID: 30209170
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive profiling of EBV gene expression in nasopharyngeal carcinoma through paired-end transcriptome sequencing.
Hu L; Lin Z; Wu Y; Dong J; Zhao B; Cheng Y; Huang P; Xu L; Xia T; Xiong D; Wang H; Li M; Guo L; Kieff E; Zeng Y; Zhong Q; Zeng M
Front Med; 2016 Mar; 10(1):61-75. PubMed ID: 26969667
[TBL] [Abstract][Full Text] [Related]
15. Vesicle-bound EBV-BART13-3p miRNA in circulation distinguishes nasopharyngeal from other head and neck cancer and asymptomatic EBV-infections.
Ramayanti O; Verkuijlen SAWM; Novianti P; Scheepbouwer C; Misovic B; Koppers-Lalic D; van Weering J; Beckers L; Adham M; Martorelli D; Middeldorp JM; Pegtel DM
Int J Cancer; 2019 May; 144(10):2555-2566. PubMed ID: 30411781
[TBL] [Abstract][Full Text] [Related]
16. Expression profiling of Epstein-Barr virus-encoded microRNAs from paraffin-embedded formalin-fixed primary Epstein-Barr virus-positive B-cell lymphoma samples.
Nourse JP; Crooks P; Keane C; Nguyen-Van D; Mujaj S; Ross N; Jones K; Vari F; Han E; Trappe R; Fink S; Gandhi MK
J Virol Methods; 2012 Sep; 184(1-2):46-54. PubMed ID: 22609801
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas.
Zhu JY; Pfuhl T; Motsch N; Barth S; Nicholls J; Grässer F; Meister G
J Virol; 2009 Apr; 83(7):3333-41. PubMed ID: 19144710
[TBL] [Abstract][Full Text] [Related]
18. Modulation of MicroRNA Cluster miR-183-96-182 Expression by Epstein-Barr Virus Latent Membrane Protein 1.
Oussaief L; Fendri A; Chane-Woon-Ming B; Poirey R; Delecluse HJ; Joab I; Pfeffer S
J Virol; 2015 Dec; 89(23):12178-88. PubMed ID: 26401047
[TBL] [Abstract][Full Text] [Related]
19. Biogenesis of Epstein-Barr virus microRNAs.
Kim DN; Lee SK
Mol Cell Biochem; 2012 Jun; 365(1-2):203-10. PubMed ID: 22350759
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Epstein-Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing.
Chen SJ; Chen GH; Chen YH; Liu CY; Chang KP; Chang YS; Chen HC
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20862214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]